As the state considers whether to adjust the required mold and yeast levels in medical cannabis products, patients and others remain concerned about the proposed change and are calling for stricter testing standards. The public comment period ended last week on the state Department of Consumer Protection’s proposed changes, which would set the total limit at 100,000 colony forming units per gram and wouldn’t allow any detectable levels of harmful breeds of mold in the Aspergillus family. The change would mean increasing the levels for one lab, while the other facility would need to lower its amount after gaining state approval last year for more mold and yeast in its products. The proposal came in December after patients complained about the state approving a request from AltaSci Labs last year to raise its limits from 10,000 units per gram to 1 million. The approval occurred via email, and patients weren’t notified of the change. State officials and AltaSci’s lab director have said the Aspergillus requirement makes the products safer. The other lab, Northeast Laboratories, left its limit at 10,000 units per gram. Some of Connecticut’s 54,000 medical marijuana patients have expressed concerns over transparency and the safety of the products after learning the state approved the change for AltaSci Labs.
420 Intel – Marijuana Industry News, 02/06/2022 19:00:00